Aptinyx's Series B Round

Aptinyx raised a round of funding on December 18, 2017.

Aptinyx is a biopharmaceutical company focused on discovery and development of transformative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for dis…

Articles about Aptinyx's Series B Round: